[Evolution of endovascular treatment compared with medical and surgical treatment in patients with aortic syndrome type B].

Gac Med Mex 2014 Dec;150 Suppl 3:298-305

Departamento de Cirugía Cardiovascular, Instituto Nacional de Cardiología Ignacio Chávez, México, D.F.

Introduction: Surgical treatment is accepted as conventional treatment of patients with acute aortic syndrome associated to ischemic complications. Promising results of thoracic endovascular aortic repair (TEVAR) has expanded its indication to a variety of thoracic aorta pathologies.

Objectives: The objective of this study was to evaluate the safety and efficacy of TEVAR during the in-hospital period and at mid-term follow-up, and compare with medical and surgical treatment in patients who presented with acute aortic syndrome (AAS) type B.

Material And Methods: Of 113 patients that fulfilled the inclusion criteria, 58 underwent endovascular treatment (Group 1), 34 had medical treatment (Group 2), and 21 had surgical treatment (Group 3).

Results: Global and cardiovascular in-hospital mortality was superior in Group 3 (p = 0.0001). Mean follow-up was 30.4 ± 12.2 months. The survival rate free from cardiovascular death was 92.5, 60.5, and 42.9, in Group 1, 2, and 3, respectively, at 36 months.

Conclusions: Our results suggest that endovascular treatment is feasible, safe, and associated with a reduction of in-hospital and mid-term major adverse cardiovascular events, and superior survival rate compared with surgical and medical treatment.

Download full-text PDF

Source
December 2014
16 Reads
0.191 Impact Factor

Publication Analysis

Top Keywords

surgical treatment
16
treatment patients
12
aortic syndrome
12
treatment group
12
endovascular treatment
12
treatment
10
acute aortic
8
medical treatment
8
survival rate
8
medical surgical
8
group
5
surgical
5
syndrome aas
4
aas type
4
monthsconclusions endovascular
4
type bmaterial
4
bmaterial methods
4
429 group
4
patients fulfilled
4
113 patients
4

Similar Publications